Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Tak Paul Peter (CIK 1873905) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Buy CADL (125,000 shares), Sell CADL (220,866 shares), Sell CADL (59,379 shares), Buy CADL (42,826 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Buy | 125,000 | $193,750 |
| 2026-09-11 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Sell | 220,866 | $2.5M |
| 2026-09-11 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Sell | 59,379 | $620,891 |
| 2025-06-26 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Buy | 42,826 | $199,997 |
Source: SEC Form 4 filings · as of 2026-09-11